SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'L41'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 353HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.66A | 1fm6D-3d5fA:36.5 | 1fm6D-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323LEU A 356LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.8A) | 1.25A | 1fm6D-3d5fA:36.5 | 1fm6D-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_X_BRLX504_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323HIS A 449LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.64A | 1fm6X-3d5fA:35.5 | 1fm6X-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 7 / 12 | CYH A 285HIS A 323LEU A 330LEU A 353HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.72A | 1zgyA-3d5fA:36.3 | 1zgyA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 356LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.8A) | 1.32A | 1zgyA-3d5fA:36.3 | 1zgyA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285GLN A 286HIS A 323LEU A 330 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.9A) | 0.65A | 2prgA-3d5fA:36.1 | 2prgA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330HIS A 449TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.77A | 2prgA-3d5fA:36.1 | 2prgA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.74A | 2prgB-3d5fA:34.9 | 2prgB-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323LEU A 330VAL A 334HIS A 449TYR A 473 | L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 1.18A | 2prgB-3d5fA:34.9 | 2prgB-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.82A | 2prgB-3d5fA:34.9 | 2prgB-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.88A | 2xkwA-3d5fA:36.3 | 2xkwA-3d5fA:61.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.86A | 2xkwA-3d5fA:36.3 | 2xkwA-3d5fA:61.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | ILE A 456ALA A 371LEU A 445ILE A 363MET A 453 | NoneNoneNoneL41 A 501 ( 4.4A)L41 A 501 ( 3.7A) | 1.20A | 2xkwB-3d5fA:33.4 | 2xkwB-3d5fA:61.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 9 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330LEU A 353LYS A 367HIS A 449LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneNoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.85A | 3adsA-3d5fA:36.3 | 3adsA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | CYH A 285GLN A 286LEU A 353PHE A 360LEU A 469 | L41 A 501 (-3.5A)NoneNoneNoneL41 A 501 (-3.8A) | 1.33A | 3adxA-3d5fA:36.3 | 3adxA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 9 / 12 | PHE A 282CYH A 285GLN A 286HIS A 323LEU A 330LEU A 353HIS A 449LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.84A | 3adxA-3d5fA:36.3 | 3adxA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323ILE A 326LEU A 330LEU A 469TYR A 473 | L41 A 501 (-3.8A)NoneL41 A 501 (-4.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 1.04A | 3cs8A-3d5fA:36.0 | 3cs8A-3d5fA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 1.20A | 3cs8A-3d5fA:36.0 | 3cs8A-3d5fA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323LYS A 367HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.8A)NoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 1.20A | 3cs8A-3d5fA:36.0 | 3cs8A-3d5fA:62.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330LEU A 353HIS A 449TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.92A | 3dzyD-3d5fA:33.8 | 3dzyD-3d5fA:50.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323LEU A 330VAL A 334HIS A 449TYR A 473 | L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 1.36A | 3dzyD-3d5fA:33.8 | 3dzyD-3d5fA:50.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330LEU A 353TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-4.8A) | 0.92A | 3dzyD-3d5fA:33.8 | 3dzyD-3d5fA:50.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323LEU A 356TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-4.8A) | 1.39A | 3dzyD-3d5fA:33.8 | 3dzyD-3d5fA:50.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 4 / 7 | GLN A 286LEU A 330VAL A 341LYS A 367 | NoneL41 A 501 (-4.9A)L41 A 501 ( 4.4A)None | 0.88A | 3g8iA-3d5fA:38.0 | 3g8iA-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 4 / 7 | GLN A 286VAL A 341LYS A 367LEU A 469 | NoneL41 A 501 ( 4.4A)NoneL41 A 501 (-3.8A) | 0.56A | 3g8iA-3d5fA:38.0 | 3g8iA-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 7 | LEU A 255GLN A 286LEU A 330VAL A 341LEU A 353 | NoneNoneL41 A 501 (-4.9A)L41 A 501 ( 4.4A)None | 0.70A | 3g8iA-3d5fA:38.0 | 3g8iA-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 7 | LEU A 255GLN A 286VAL A 341LEU A 353LEU A 469 | NoneNoneL41 A 501 ( 4.4A)NoneL41 A 501 (-3.8A) | 0.60A | 3g8iA-3d5fA:38.0 | 3g8iA-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 7 / 12 | CYH A 285HIS A 323LEU A 330LYS A 367HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.65A | 3g9eA-3d5fA:37.0 | 3g9eA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | HIS A 323LEU A 330VAL A 334LYS A 367HIS A 449TYR A 473 | L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneNoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 1.39A | 3g9eA-3d5fA:37.0 | 3g9eA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 10 / 10 | VAL A 281PHE A 282GLN A 286ILE A 326MET A 329LEU A 339VAL A 341VAL A 348LEU A 353LYS A 367 | L41 A 501 ( 4.7A)L41 A 501 ( 4.9A)NoneNoneNoneL41 A 501 (-4.8A)L41 A 501 ( 4.4A)NoneNoneNone | 0.40A | 3gwxA-3d5fA:39.9 | 3gwxA-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 10 | VAL A 281PHE A 360LEU A 339VAL A 341VAL A 348LEU A 353 | L41 A 501 ( 4.7A)NoneL41 A 501 (-4.8A)L41 A 501 ( 4.4A)NoneNone | 1.31A | 3gwxA-3d5fA:39.9 | 3gwxA-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | CYH A 285THR A 288LEU A 339ILE A 363ILE A 364 | L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 (-4.8A)L41 A 501 ( 4.4A)L41 A 501 ( 4.2A) | 1.20A | 3gwxA-3d5fA:39.9 | 3gwxA-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 12 / 12 | CYH A 285THR A 288THR A 289THR A 292HIS A 323LEU A 330ILE A 363ILE A 364HIS A 449MET A 453LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 (-3.5A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 ( 4.4A)L41 A 501 ( 4.2A)L41 A 501 (-3.9A)L41 A 501 ( 3.7A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.54A | 3gwxA-3d5fA:39.9 | 3gwxA-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 12 / 12 | CYH A 285THR A 288THR A 289THR A 292GLU A 295HIS A 323LEU A 330ILE A 333LYS A 367HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 (-3.5A)NoneNoneL41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneNoneL41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.46A | 3gwxB-3d5fA:38.2 | 3gwxB-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | GLU A 291HIS A 323LEU A 330LYS A 367HIS A 449TYR A 473 | NoneL41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 1.16A | 3gwxB-3d5fA:38.2 | 3gwxB-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 12 / 12 | LEU A 255PHE A 282ARG A 284GLN A 286ILE A 326MET A 329LEU A 339VAL A 341VAL A 348LEU A 353ILE A 364MET A 453 | NoneL41 A 501 ( 4.9A)NoneNoneNoneNoneL41 A 501 (-4.8A)L41 A 501 ( 4.4A)NoneNoneL41 A 501 ( 4.2A)L41 A 501 ( 3.7A) | 0.71A | 3gwxB-3d5fA:38.2 | 3gwxB-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 360LEU A 339VAL A 341VAL A 348LEU A 353ILE A 364 | NoneL41 A 501 (-4.8A)L41 A 501 ( 4.4A)NoneNoneL41 A 501 ( 4.2A) | 1.25A | 3gwxB-3d5fA:38.2 | 3gwxB-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285THR A 288ILE A 363HIS A 449TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 ( 4.4A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.90A | 3sp6A-3d5fA:37.1 | 3sp6A-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285THR A 288VAL A 341HIS A 449TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 ( 4.4A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.51A | 3sp6A-3d5fA:37.1 | 3sp6A-3d5fA:70.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 12 / 12 | LEU A 255PHE A 282CYH A 285THR A 288THR A 289HIS A 323ILE A 326LEU A 339VAL A 348ILE A 364HIS A 449TYR A 473 | NoneL41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-4.8A)NoneL41 A 501 ( 4.2A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.96A | 3sp9A-3d5fA:38.6 | 3sp9A-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_B_IL2B901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 12 / 12 | LEU A 255VAL A 281PHE A 282CYH A 285THR A 288THR A 289HIS A 323ILE A 326LEU A 339VAL A 348HIS A 449TYR A 473 | NoneL41 A 501 ( 4.7A)L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.0A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-4.8A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.97A | 3sp9B-3d5fA:38.7 | 3sp9B-3d5fA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VN2_A_TLSA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 7 / 12 | PHE A 282CYH A 285ILE A 326LEU A 330LEU A 353HIS A 449TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)NoneL41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.61A | 3vn2A-3d5fA:36.9 | 3vn2A-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EMA_A_BRLA601_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.75A | 4emaA-3d5fA:35.7 | 4emaA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.76A | 4o8fA-3d5fA:34.3 | 4o8fA-3d5fA:62.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.61A | 4o8fA-3d5fA:34.3 | 4o8fA-3d5fA:62.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.62A | 4o8fB-3d5fA:33.6 | 4o8fB-3d5fA:62.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | HIS A 323LEU A 330VAL A 334HIS A 449TYR A 473 | L41 A 501 (-3.8A)L41 A 501 (-4.9A)NoneL41 A 501 (-3.9A)L41 A 501 (-4.8A) | 1.13A | 4o8fB-3d5fA:33.6 | 4o8fB-3d5fA:62.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QYN_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | ILE A 249THR A 292THR A 288LEU A 330LEU A 339 | NoneNoneL41 A 501 (-3.0A)L41 A 501 (-4.9A)L41 A 501 (-4.8A) | 1.37A | 4qynB-3d5fA:undetectable | 4qynB-3d5fA:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RTB_A_SAMA501_0 (HYDG PROTEIN) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | TYR A 473VAL A 315LEU A 296LEU A 469LEU A 465 | L41 A 501 (-4.8A)NoneNoneL41 A 501 (-3.8A)None | 1.36A | 4rtbA-3d5fA:undetectable | 4rtbA-3d5fA:21.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLD_A_BRLA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 7 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.65A | 4xldA-3d5fA:36.5 | 4xldA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 8 / 12 | PHE A 282CYH A 285HIS A 323ILE A 326HIS A 449LEU A 465LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)NoneL41 A 501 (-3.9A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.85A | 4xumA-3d5fA:36.2 | 4xumA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_D_BRLD501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.73A | 5ji0D-3d5fA:36.3 | 5ji0D-3d5fA:62.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.63A | 5y2oA-3d5fA:36.5 | 5y2oA-3d5fA:12.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285HIS A 323LEU A 330LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.70A | 5y2oA-3d5fA:36.5 | 5y2oA-3d5fA:12.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | LEU A 255PHE A 282CYH A 285GLN A 286LEU A 330 | NoneL41 A 501 ( 4.9A)L41 A 501 (-3.5A)NoneL41 A 501 (-4.9A) | 0.60A | 5y2tA-3d5fA:35.9 | 5y2tA-3d5fA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | LEU A 255CYH A 285GLN A 286ILE A 326LEU A 330HIS A 449 | NoneL41 A 501 (-3.5A)NoneNoneL41 A 501 (-4.9A)L41 A 501 (-3.9A) | 0.75A | 5y2tB-3d5fA:34.3 | 5y2tB-3d5fA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 4 / 6 | CYH A 285HIS A 323HIS A 449TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.60A | 5ycnA-3d5fA:36.7 | 5ycnA-3d5fA:62.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 4 / 6 | PHE A 282CYH A 285HIS A 323TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.64A | 5ycnA-3d5fA:36.7 | 5ycnA-3d5fA:62.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 6 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449LEU A 469TYR A 473 | L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.67A | 5ycpA-3d5fA:37.1 | 5ycpA-3d5fA:13.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323LEU A 469TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)L41 A 501 (-3.8A)L41 A 501 (-3.8A)L41 A 501 (-4.8A) | 0.72A | 5ycpA-3d5fA:37.1 | 5ycpA-3d5fA:13.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MD4_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3d5f | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA (Homosapiens) | 7 / 12 | PHE A 282CYH A 285GLN A 286HIS A 323LEU A 330HIS A 449TYR A 473 | L41 A 501 ( 4.9A)L41 A 501 (-3.5A)NoneL41 A 501 (-3.8A)L41 A 501 (-4.9A)L41 A 501 (-3.9A)L41 A 501 (-4.8A) | 0.78A | 6md4A-3d5fA:36.0 | 6md4A-3d5fA:15.79 |